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Rapidly dividing cultured human cells, such as fibroblasts and lymphoblasts, 
are  able  to derive all of their required cholesterol from plasma low density 
lipoprotein (LDL)  1  that is present in the culture medium (reviewed in references 
1 and 2). The ability of cultured cells to utilize LDL-cholesterol is dependent on 
the presence of a  high affinity cell surface receptor that binds LDL and thus 
enhances its rate of cellular uptake and lysosomal degradation (3-7).  When 
grown continuously in  the  presence  of LDL,  cultured  fibroblasts  express  a 
relatively low number of LDL receptors that is just sufficient to supply enough 
cholesterol to balance cellular sterol losses and to allow for normal cell growth. 
Under these conditions, the amount of cholesterol derived from the degradation 
of LDL is  sufficient to supply the cell's cholesterol needs and to maintain a 
suppression of endogenous cholesterol synthesis (8-12). 
When rapidly dividing cells are deprived of  LDL, they simultaneously  develop both an 
enhanced number of LDL receptors  and an enhanced rate of cholesterol synthesis, the 
latter mediated through an increase  in the activity of a  rate-controlling enzyme,  3- 
hydroxy-3-methylglutaryl  coenzyme A reductase (HMG CoA reductase)  (1, 8,  11,  12). 
Under these conditions, the subsequent exposure of  the cells to LDL is followed by a rapid 
uptake and degradation of the lipoprotein through the receptor mechanism, which leads 
initially to a suppression of cholesterol synthesis and subsequently to a reduction in the 
number of LDL receptors  (1,  8,  11,  12). Cultured fibroblasts  and lymphoblasts from 
subjects with homozygous familial hypercholesterolemia  (FH) lack LDL receptors  and 
are therefore unable to bind, take up, and degrade the lipoprotein with high affinity (3-7, 
13). Thus, when grown in the presence of LDL, the FH homozygote cells, in contrast to 
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normal cells, derive the cholesterol that they require for cell growth not from plasma 
lipoproteins but from endogenous synthesis (1, 8, 9). 
The pattern of regulation of cholesterol synthesis is altered afar cultured fibroblasts 
have become confluent and ceased to divide. When incubated in the absence of lipopro- 
teins,  confluent  fibroblasts  from both  normal  subjects  and  FH  homozygotes exhibit 
relatively low rates of HMG CoA reductase activity and cholesterol synthesis as com- 
pared with growing cells (8). Moreover, when deprived of lipoproteins, normal confluent 
fibroblasts express only a  relatively small number of LDL receptors (4). Both of these 
observations suggest that the sterol requirements of confluent cells are lower than those 
of dividing cells. Consistent with this conclusion is the additional finding that HMG CoA 
reductase activity can be enhanced in confluent fibroblasts from normal subjects and FH 
homozygotes by addition to the culture medium of agents such as lipoprotein-deficient 
serum (LPDS) and high density lipoprotein (HDL) that are believed to remove cholesterol 
from cells and hence increase their sterol requirement (8). 
To begin to study directly how the LDL receptor functions in certain nondividing cells 
in the body, we have recently turned to human lymphocytes freshly isolated from the 
bloodstream. We previously showed that freshly isolated lymphocytes expressed an LDL 
receptor with properties similar to that of cultured fibroblasts and lymphoblasts (14). As 
expected from the findings in cultured  cells (1,  11), the number of LDL receptors on 
lymphocytes was relatively low immediately after their removal from the bloodstream 
where they had been exposed to plasma LDL (14). However, when lymphocytes were 
incubated in medium devoid of LDL, the number of LDL receptors increased and hence 
the ability of the cells to take up and degrade LDL rose by 10-20-fold  over a 48- to 72-h 
period (14). This increase in the number of LDL receptors could be prevented by inclusion 
of LDL, but not HDL, in the initial incubation medium (14). Freshly isolated lymphocytes 
from patients  with  homozygous FH  exhibited  less than  5%  of normal  LDL receptor 
activity, even after incubation for 72 h  in the absence of lipoproteins (14). 
In  the  present  studies,  we  have  used  the  lymphocyte model  to  determine 
whether the LDL receptor plays a role in the regulation of cholesterol synthesis 
in nondividing cells that have been freshly isolated from the body. The results 
indicate  that:  (a)  sterol synthesis  in fresh lymphocytes is  subject to feedback 
suppression  mediated  specifically by LDL,  (b)  this  regulation  is  achieved  at 
least in part through an interaction of LDL with the LDL receptor, and (c) this 
regulation resembles the pattern observed in confluent, nondividing fibroblasts 
in that the requirement for cholesterol is low and is enhanced by agents that are 
believed to remove cholesterol from cells. 
Materials and Methods 
Materials.  [2-14C]Acetic  acid,  sodium  salt (59 mCi/mmol)  was purchased from Amersham/ 
Searle  Corp. (Arlington  Heights, Ill.) Tissue culture supplies and chemicals were obtained from 
sources as previously reported (8, 14). 
Subjects.  Normal subjects were healthy individuals  who had total plasma cholesterol  levels 
less than 220 mg/dl and no family history of FH. The four patients with homozygous FH and the 
two patients with abetalipoproteinemia had the typical features of the indicated disorder (15, 16). 
Their clinical  and biochemical data are summarized in Table I. Informed written consent was 
obtained from each subject or from the parents. 
Lipoproteins and Serum.  Human LDL (density 1.019-1.063 g/ml), human HDL (density 1.065- 
1.215 g/ml), and human LPDS (density >1.215 g/ml) were obtained from the plasma of individual 
healthy subjects and prepared by differential ultracentrifugation (8). The concentration  of LDL 
and HDL is expressed in terms of their protein content.  The mass ratio of total cholesterol  to 
protein in LDL and HDL was  1.6:1 and  1:3, respectively.  LDL was radiolabeled  with  1~5I as 
previously described  (3). HO,  FAUST,  BILHEIMER,  BROWN,  AND  GOLDSTEIN 
TABLE  I 
Clinical and Biochemical Data on Patients with Homozygous FH and 
A betalipoproteinemia 
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Patient 
Plasma cholesterol* 
Age  Sex  Plasma tri-  Phenotype  of eul-  Drug therapy 
Total  LDL  glycerides*  tured fibroblasts$ 
mgldl  mg/dl 
Homozygous FH 
M.C.§  8  F  625  590  112  Receptor-negative  Inderal,  nicotinic  acid 
K.W.  13  F  582  549  81  Receptor-negative  Ferrous  gluconate 
D.R.  15  F  545  512  119  Receptor-defective  Ferrous  gluconate 
B.H.  21  M  723  685  202  Receptor-negative  Ferrous glueonate 
Abetalipoproteinemia 
M.W.  14  M  35  0  3  Vitamins A  and E 
A.C.  34  M  40  0  6  -  Vitamins  A  and E 
* Measured by previously  described  methods (38). 
Determined  in cultured fibroblaste by previously  described criteria (27). 
§ An end-to-side  portacaval  shunt was performed  19 mo before  the current studies (38). 
Isolation  and Prior Incubation of Lymphocytes.  Peripheral blood lymphocytes were isolated 
under sterile conditions by a  modification (14)  of the method of Boyiim (17).  Each washed cell 
pellet containing 10-15  x  l0  s mononuclear cells from 10 ml of venous blood was resuspended in 
medium A (RPMI-1640 medium [Grand Island Biological Co., Grand Island, N. Y.] with penicillin 
[100  U/ml] and streptomycin [100 ~g/ml]) containing 10%  (vol/vol) human LPDS  (final protein 
concentration, 5 mg]ml). The cell suspensions were then combined and divided into portions of 2 
ml (each containing 3-5 x  l0  s cells) which were transferred to 30-ml plastic culture flasks. 
Cell  viability,  as  assessed  by  erythrosin  B  exclusion,  was  routinely  determined  for  each 
lymphocyte preparation and was greater than 90% under all experimental conditions. Purity of 
the cell preparations was assessed after staining smears with Wright-Giemsa. Differential counts 
revealed that 90-95% of the mononuclear cells both before and after incubation were morphologi- 
cally identifiable as lymphocytes. By the functional criterion of latex particle ingestion (18), about 
5% of the mononuclear cells were identified as monocytes. When these monocytes were quantita- 
tively removed from the preparations by adherence to plastic, the rate of cholesterol synthesis in 
the mononuclear preparation was not altered either at zero time or after incubation in LPDS and 
the response to LDL was not affected in either the FH homozygote or the normal cells. Hence, in 
most experiments, the small number of contaminating monocytes was not removed. 
Incorporation  of [2-14C]Acetate into Cholesterol  by Intact Lymphocytes.  Cholesterol synthesis 
from [2-14C]acetate was measured by either of two methods. Method 1- Lymphocytes from each 
culture flask were harvested by centrifugation (1,000 rpm, 10 min, 24°C) and washed once with 15 
ml of medium A. The cells from several flasks were pooled together and resuspended in 0.24 ml of 
medium A  at a  final concentration of about 20-60  ×  10  e cells/ml (1-3  mg cellular protein/ml). 
Duplicate portions (10 ~tl) of the lymphocyte suspension were removed for measurement of cellular 
protein  content  and  another  set  of duplicate  aliquots  (0.1  ml)  was  incubated in  glass  tubes 
containing 1 ml of medium A supplemented with 10% LPDS and 2.5 mM [2-14C]acetate (58 cpm/ 
pmol). The tubes were gassed with 95% O2: 5% CO2, capped, and incubated with shaking at 37°C for 
4 or 5 h. The incubations were terminated by the addition of 0.25 ml of 50% K OH, 0.5 ml of ethanol, 
and 105 cpm of [1,2-3H]cholesterol (50 Ci/mmol) as an internal standard.  Each sample was then 
autoclaved (15 pounds/inch  2, 240°F, 30 rain), after which 1 ml of ethanol was added. The nonsapon- 
ifiable lipids were then extracted with three 10-ml portions of petroleum ether, and the pooled 
ether extracts were backwashed with 2 ml of 0.1-N sodium hydroxide followed by 2 ml of distilled 
water. The [14C]squalene (Rf =  0.71),  [14C]lanosterol, and other 4,4-dimethyl sterols (Rf = 0.44), 
and [l~C]cholesterol (R  s =  0.31) were isolated by thin-layer chromatography and quantified (19). 
The recovery of the added [~H]cholesterol, which averaged 90%, was used to correct for procedural 
losses of synthesized [14C]cholesterol. Method 2- This method differs from Method 1 primarily in 
that the  [~4C]acetate was  added directly to  the flask  in  which  the  cells had been previously 
incubated, thus avoiding the necessity for centrifuging the cells immediately before the isotope 
incorporation was studied. Each flask of lymphocytes containing 180-400 fig of cell protein in 2 ml 
of medium A and 10% LPDS received 50 ~l of [2-~4C]acetate (final concentration, 2.5 mM; sp act, 
29-58 cpm/pmol). The cells were incubated at 37°C in a humidified incubator (5% CO2 in air) for 2 1534  CHOLESTEROL  SYNTHESIS  IN  HUMAN  LYMPHOCYTES 
or 4 h. One portion of the cells and medium from each flask (0.2 ml) was removed, transferred to a 
400-iLl microfuge tube, and centrifuged (12,000 rpm, 2 min, 4°C), and the resulting cell pellet was 
used for measurement of protein content (14). Incubations were terminated by the addition of 0.5 
ml of 50% KOH,  1 ml of ethanol, and 105 cpm of [1, 2-3H] cholesterol (50 Ci/mmol) as an internal 
standard.  The  content of  [l~C]cholesterol was measured  as  described  for  Method  1  except for 
appropriate volume adjustments for solvents. For all experiments, blank reactions were routinely 
conducted in which cells were omitted from the incubation mixture. 
Incorporation of[l-l~C]Oleate  into Lipids by Intact L ymphocytes.  After prior incubation at 37°C 
in medium A containing 10% LPDS and the indicated additions, each flask of cells received 50 ill of 
[~4C]oleate bound to  albumin  (final  concentration and  sp  act,  0.1  mM  and  12,000  cpm/nmol, 
respectively) (20). The cells were incubated at 37°C in a humidified incubator (5% CO2 in air) for 
the indicated time, after which the cells and medium were separated by centrifugation (1,000 rpm, 
5 min, 4°C).  Each cell pellet was washed three times with 5 ml of phosphate-buffered saline, after 
which the ~4C-labeled lipids were isolated by thin-layer chromatography and quantified (20). 
Measurement  of  Cellular  Content  of  Free  and  Esterified  Cholesterol  in  Lympho- 
cytes.  Lymphocytes were isolated and washed twice in medium A  as described above. The cell 
pellet was  washed  once  more  in  5  ml  of phosphate-buffered saline.  The final cell  pellet was 
resuspended in 0.24 ml of water.  Duplicate portions  (10 tL1) were removed for determination of 
protein content, and 0.2 ml of the remaining suspension was extracted with chloroform:methanol 
(21). The free and esterified cholesterol fractions were separated on silicic acid:celite columns, and 
the cholesterol content in each fraction was measured by gas-liquid chromatography as described 
for fibroblasts (9). 
Other Assays.  Protein was determined by a  modification of the method of Lowry et al.  (22), 
with bovine serum albumin as a standard. The total proteolytic degradation of 125I-LDL by intact 
lymphocytes was determined as previously described (14). 
Results 
When normal human lymphocytes were incubated for 48 h in the absence of 
lipoproteins and were then exposed to [14C]acetate, the isotope was incorporated 
into nonsaponifiable lipids.  Fractionation of the nonsaponifiable lipids by thin- 
layer chromatography showed three radiolabeled products that corresponded in 
mobility to authentic samples of squalene, lanosterol, and cholesterol. The time- 
course in Fig.  1 shows that initially the rate of [14C]acetate incorporation into 
[14C]lanosterol exceeded the rate of incorporation into [14C]cholesterol. However, 
after 1-2 h, the rate of accumulation of [14C]lanosterol began to decline whereas 
[14C]cholesterol continued to accumulate, a finding that is consistent with the 
known precursor-product relationship of these two sterols (23). Validation ex- 
periments  indicated  that  the  rate  of  incorporation  of  [~4C]acetate into 
[14C]cholesterol was linear with time for at least 6 h, linear with respect to the 
mass of cells in the incubation medium up to 3 mg of cellular protein,  and 
saturating with respect to [~4C]acetate at concentrations above 2 mM. 
When normal lymphocytes were freshly isolated from the bloodstream, the 
rate of [14C]acetate incorporation into [~4C]cholesterol was low (Fig.  2A). How- 
ever, when the cells were incubated in medium containing LPDS, the rate of 
[14C]acetate incorporation into [~4C]cholesterol  increased by more than sevenfold 
over a 56-h interval. (In other experiments in which lymphocytes  from different 
subjects were studied,  the rate of cholesterol synthesis from  [~4C]acetate in- 
creased 5-15-fold after incubation for 48-72 h in the absence of lipoproteins.) The 
addition of LDL to the incubation medium at 56 h led to a 75% reduction in the 
rate of cholesterol synthesis when measured 9 h later (Fig.  2A). A pronounced 
inhibition  was  also  achieved by  addition  of a  mixture of 25-hydroxycholes- 
terol plus cholesterol, a combination of sterols that also suppresses cholesterol HO,  FAUST,  BILHEIMER,  BROWN,  AND  GOLDSTEIN  1535 
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Fro. 1.  Time-course  of  incorporation  of  [14C]acetate  into  nonsaponifiable  lipids  in  normal 
lymphocytes. Lymphocytes from a healthy  24-yr-old  female (M. S.)  were incubated at  37°C 
in  medium A containing 10% lipoprotein-deficient  serum  for  48  h,  after  which  the  incorpora- 
tion  of  [14C]acetate  into  the  indicated  "C-labeled intermediates was  measured  by Method 1. 
The results  are expressed as the picomoles of  [14C]acetate  incorporated  into  the indicated 
lipid  per incubation tube.  Each tube contained 100/~g  of  total  cell  protein. 
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FIG. 2.  Regulation of  cholesterol  synthesis  from ["C]acetate  in  normal (A)  and FH homo- 
zygote (B) lymphocytes after  incubation in the absence of  lipoproteins.  Lymphocytes from 
a healthy 22-yr-old  male (J. C.) and a 13oyr-old  female with homozygous FH (K. W.) were 
incubated at  37°C in  flasks  containing medium A with  10% lipoprotein-deficient  serum. The 
incorporation  of  [14C]acetate  into  [~4C]cholesterol  was measured in duplicate  flasks  at  the 
indicated  interval  by Method 2 with a 4-h  labeling  period.  After incubation for  56 h in  the 
absence  oflipoproteins,  duplicate  sets  of  flasks  received  the following  additions:  none;  20/~g 
protein/ml of LDL; or a mixture of 1.2 /~g/ml  of 25-hydroxycholesterol  and 15 /~g/ml  of 
cholesterol  added  in  5/~l  of  ethanol.  The  incubations  were continued for  9  h, after  which  the 
incorporation  of [~4C]acetate  into  [l~C]cholesterol  was measured by Method 2 with a 4-h 
labeling  period.  Each bar  represents  the average and  range of  the duplicate  incubations. 1536  CHOLESTEROL  SYNTHESIS  IN  HUMAN  LYMPHOCYTES 
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synthesis in fibroblasts (24) and in other cell types (25) (Fig.  2A). Fig. 3 shows 
that HDL,  in contrast to  LDL,  did not suppress  cholesterol synthesis when 
added to normal lymphocytes that had first been incubated for 48  h  in the 
absence of lipoproteins. As with other cell systems tested to date (8,  10,  26), 
suppression of cholesterol synthesis by LDL in normal human lymphocytes  was 
associated with a parallel decrease in the activity of HMG CoA reductase as 
measured in cell-free extracts (data not shown). 
To determine whether the suppression of cholesterol synthesis by LDL in 
lymphocytes required the action of the LDL receptor, we studied the ability of 
LDL to suppress sterol synthesis in FH homozygote cells when LDL was added 
after sterol synthesis had been elevated by prior incubation of  the cells in LPDS. 
Fig. 2B shows that when lymphocytes from one FH homozygote were isolated 
from her bloodstream, the rate of [14C]acetate incorporation into [14C]cholesterol 
was similar to that in normal cells. Moreover, just as in normal cells, the rate of 
sterol synthesis rose markedly when the cells were incubated for 56 h in LPDS. 
However, in contrast to normal cells, the subsequent addition of LDL to the FH 
homozygote cells did not produce a significant suppression of sterol synthesis. 
On the other hand, these mutant cells responded normally to the addition of 25- 
hydroxycholesterol  plus cholesterol (Fig. 2B). A similar time-course of induction 
of cholesterol synthesis from [14C]acetate was observed when the experiment in 
Fig. 2 was repeated with lymphocytes from two different normal subjects and 
two different FH homozygotes. 
Fig. 4 shows that the resistance of FH homozygote lymphocytes to the action 
of LDL persisted even at levels of LDL that were 20-fold higher than the level of 
LDL  needed to  achieve 50%  suppression  of cholesterol synthesis in  normal 
lymphocytes (5  ~g protein/ml). When freshly isolated from the bloodstream, 
Fro.  3.  Ability of plasma lipoproteins to suppress cholesterol synthesis from [14C]acetate 
in  normal  lymphocytes that  had  been subjected to  prior  incubation in  the  absence of 
lipoproteins. Lymphocytes from a healthy 23-yr-old male (R. H.) were incubated at 37°C in 
medium A containing 10% lipoprotein-deficient  serum. After 48 h, each flask received the 
indicated final concentration of one of the following lipoproteins: I,  none; b, HDL; or O, 
LDL. The incubations were continued for an additional 24 h, after which the incorporation 
of [14C]acetate  into [14C]cholestero]  was measured by Method 1 with a  5-h labeling period. 
Each value represents either the average of triplicate incubations (i) or single incubations 
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FIG. 4.  Effect  of  LDL on cholesterol  synthesis  from [14C]acetate  in  normal (0, A) and FH 
homozygote (©, A) lymphocytes  that had been  subjected  to  prior  incubation in  the  absence 
of  lipoproteins.  Lymphocytes were  isolated  in  experiment  A from  a healthy  23-yr-old  female 
(P. H.) and a 13-yr-old  female with homozygous FH (K. W.) and in experiment B from a 
healthy 11-yr-old  male (D. C.) and an 8-yr-old  female with homozygous FH (M. C.).  After 
the  cells  had  incubated at  37°C for  55  h in  the  absence  of  lipoproteins,  each  flask  received  the 
indicated  final  concentration  of  LDL. The incubations  were  continued for  an additional  9  h, 
at which time the incorporation of [14C]acetate  into ['4C]cholesterol  was measured by 
Method 2 with a 4-h labeling period. Each value represents the average of duplicate 
incubations.  The 100%  of  control  values  for  P. H.,  K. W., D. C.,  and  M. C.  were  370,  195,392, 
and 1,171  pmol  of  [~4C]acetate  converted  to  [~4C]cholesterol/h  per  mg protein,  respectively. 
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normal and FH homozygote lymphocytes  showed a similar rate of incorporation 
of [14C]acetate into saponifiable lipids  (including phospholipids and triglycer- 
ides) and this rate was unaffected by incubation for three days in the absence of 
lipoproteins or by the addition of LDL. 
In cultured human fibroblasts  (20) and suspended lymphoid cells (10), the 
uptake and degradation of LDL through the receptor mechanism leads to the 
release of free cholesterol and this not only suppresses cholesterol synthesis but 
it also increases, the rate at which the cells incorporate exogenous ['4C]oleate 
into cholesteryl [14C]oleate. Stimulation of cholesteryl ester formation can also 
be achieved by exposing these cultured cells to a mixture of 25-hydroxycholes- 
terol plus cholesterol, but not to HDL (20, 27). To determine whether a similar 
phenomenon occurred in isolated lymphocytes, normal cells were incubated for 
67 h in the absence of lipoproteins, after which they were exposed to [14C]oleate 
in the presence of LDL, HDL, or the sterol mixture. In experiments not shown, 
LDL and the sterol mixture, but not HDL, caused a  marked increase in the 
incorporation of [14C]oleate into cholesteryl [~4C]esters. On the other hand, none 
of these agents had a significant effect on the incorporation of [~4C]oleate into 
phospholipids or triglycerides. That the stimulation of cholesteryl ester forma- 
tion induced by addition of LDL required the LDL receptor is indicated by the 
data in Fig. 5A showing that the FH homozygote lymphocytes failed to develop 
an enhanced rate of incorporation of [~4C]oleate into cholesteryl [~4C]oleate  when 
incubated with LDL.  The data in Fig. 5B show that LDL had no effect on the 
incorporation of [14C]oleate into triglycerides in either the normal or FH homo- 
zygote cells. 1538  CHOLESTEROL  SYNTHESIS  IN  HUMAN  LYMPHOCYTES 
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FIG.  5.  Effect of LDL on the incorporation of [14C]oleate into cholesteryl esters (A) and 
triglycerides (B) in normal (@) and FH homozygote (O) lymphocytes that had been sub- 
jected to prior incubation in the absence of lipoproteins. Lymphocytes from a healthy 27-yr- 
old female (S. D.) and a 13-yr-old female with homozygous FH (K. W,) were incubated for 66 
h  in flasks containing medium A  with 10% lipoprotein-deficient serum,  after which each 
flask  received  0.1  mM  [~4C]oleate  and  the  indicated  final  concentration  of LDL.  The 
incubations were continued for an additional 8 h, at which time the cells were harvested for 
measurement of the cellular content ofcholesteryl [14C]esters (A) and [l~C]triglycerides (B). 
Each value represents a  single incubation, 
In  contrast  to  cultured fibroblasts  from FH  homozygotes, which manifest 
enhanced cholesterol synthesis in the presence of whole serum containing LDL 
(8,  28,  29),  lymphocytes from FH homozygotes, when isolated fresh from the 
bloodstream, showed a normal rate of cholesterol synthesis (Fig. 2B). To docu- 
ment this finding, a series of screening experiments was conducted in which the 
rate of [14C]acetate incorporation into [14C]cholesterol was measured in freshly 
isolated lymphocytes from 17 normal subjects, 4 FH homozygotes, and 2 patients 
with abetalipoproteinemia. Whereas the rates of cholesterol synthesis in lym- 
phocytes from all four FH homozygotes were within the normal range, the rates 
in both patients with abetalipoproteinemia were above the normal range (Fig. 
6).  One of these patients,  M.  W.,  had a  cholesterol synthesis rate that was 
fourfold above the mean rate of the normal subjects and the other patient, A. C., 
exhibited a  rate that was twofold above the normal mean. The results were 
similar whether the incubations were conducted for 2 h in an atmosphere of 20% 
oxygen (open symbols in Fig. 6) or for 5 h in an atmosphere of 95% oxygen (closed 
symbols in Fig. 6). 
Table II shows that the content of free and esterified cholesterol in lympho- 
cytes as measured by gas-liquid chromatography was similar whether the cells 
were removed from patients with abetalipoproteinemia (serum cholesterol be- 
low 40 mg/dl), normal subjects (serum cholesterol of about 200 mg/dl), or FH 
homozygotes (serum cholesterol above 600 mg/dl). 
The preceding experiments on suppression of cholesterol synthesis by LDL 
were conducted after the lymphocytes had first been incubated for 48-72 h in the 
absence of lipoproteins under conditions in which the cells had developed a 
maximal number of LDL receptors (14) as well as an enhanced rate of sterol HO,  FAUST,  BILHEIMER,  BROWN,  AND  GOLDSTEIN  1539 
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FIG.  6.  Cholesterol synthesis from [14C]acetate in freshly isolated lymphocytes from nor- 
mal  subjects,  patients  with  homozygous  FH,  and  patients  with  abetalipoproteinemia. 
Lymphocytes were isolated from 10 ml of venous blood obtained from each of the indicated 
subjects. The incorporation of [14C]acetate into [14C]cholesterol was measured by one of the 
two procedures described in Methods. Closed symbols refer to Method 1 with a  5-h incuba- 
tion period.  Open  symbols refer to  Method 2  with  a  2-h incubation period.  Each  value 
represents the average of duplicate incubations corresponding to the lymphocytes from 5 ml 
of venous blood. For the normal subjects, each closed symbol represents a different subject 
(n =  17). The 17 normal subjects consisted of 8 females and 9 males whose mean age was 23 
yr  (range,  11-32 yr).  12 of the normal subjects who were studied by Method 1 were also 
studied by Method 2 (open symbols). The clinical data on the patients with homozygous FH 
and abetalipoproteinemia are provided in Table I.  For the normal subjects, the boxed-in 
areas indicate 2 SD above and below the mean value. 
synthesis. Immediately after their isolation from the bloodstream, normal lym- 
phocytes possess only a small number of LDL receptors (14). Moreover, if LDL is 
included in the incubation medium from the time at which the cells are isolated, 
the subsequent development of an enhanced number of LDL receptors is pre- 
vented (14). In view of these observations, we performed a series of experiments 
to determine whether the addition of LDL to freshly isolated lymphocytes at a 
time when the cells expressed only a  small number of LDL receptors would 
suppress the subsequent induction of cholesterol synthesis. The data in Fig. 7 
show that the addition of low concentrations of LDL to normal lymphocytes at 
zero time did suppress the induction of cholesterol synthesis that otherwise 
occurred when the cells were incubated for 48 h in the absence of lipoproteins. 
On the other hand,  the addition of HDL at zero time failed to suppress the 
induction of cholesterol synthesis. 
The experiment in Fig. 8A shows that LDL added to lymphocytes  from an FH 
homozygote at zero time had a significant ability to suppress the induction of 
cholesterol synthesis despite the fact that these mutant cells have a  marked 
deficiency in  LDL  receptors.  The  data  in  Fig.  8B  show  that  in  the  same 
experiment lymphocytes  from the same FH homozygote failed to show any LDL- 
mediated suppression of cholesterol synthesis when the lipoprotein was added 
after the cells had been incubated for 56 h in the absence of lipoproteins (Fig. 
8B). Similar results were observed in lymphocytes  from three other FH homozy- 
gotes. 1540  CHOLESTEROL  SYNTHESIS  IN  HUMAN  LYMPHOCYTES 
TABLE  II 
Content of Free and Esterified Cholesterol in Freshly Isolated 
Lymphocytes  Obtained from Normal Subjects and Patients with 
Abetalipoproteinemia  and Homozygous  FH 
Subject providing cells  Age  Sex 
Cholesterol content 
Free  Esterified 
yr  pg sterol/mg protein 
Normal subjects 
D.C.  11  M  21  0.38 
J.W.  12  M  37  0.84 
L.L.  22  F  35  0.64 
C.L.  23  M  31  1.03 
S.M.  24  M  46  0.76 
M.S.  24  F  22  0.62 
G.B.  30  F  44  0.36 
M.E.  30  F  32  0.62 
S.B.  32  M  27  0.54 
Mean -  SEM  33  -+ 2.9  0.64 +_  0.07 
Abetalipoproteinemia 
M.W.  14  M  37  0.73 
A.C.  34  M  49  0.35 
FH homozygotes 
M.C.  8  F  29  0.38 
D.R.  15  F  37  0.44 
B.H.  21  M  28  1.00 
Mean +- SEM  31  _+ 2.9  0.61  -+ 0.19 
Lymphocytes were isolated from 10 ml of venous blood obtained from each of 
the indicated subjects. The cellular content of free and esterified cholesterol in 
the  freshly isolated lymphocytes was determined as described in  Methods. 
Each value represents the average of duplicate determinations. 
The LDL-mediated suppression of induction of cholesterol synthesis in the FH 
homozygote  cells occurred under conditions in which the degradation of 125I-LDL 
was far below normal (Fig.  9). In this experiment, freshly isolated normal and 
FH homozygote lymphocytes  were incubated for 72 h in the presence of 125I-LDL 
at a concentration of 25 ftg protein/ml, a level that is sufficient to suppress the 
induction of sterol synthesis in both types of cells (compare with Fig. 8). Under 
these conditions, after 72 h the total amount of 125I-LDL degraded by the normal 
cells was 10-fold greater than that degraded by the FH homozygote cells. It is 
important to note that the rate of 125I-LDL degradation in the normal lympho- 
cytes was relatively low and nearly linear from zero time since the concentration 
of 125I-LDL added (25  ~g protein/ml) was sufficient to suppress the 10-20-fold 
increase in the number of LDL receptors that would have otherwise occurred 
had LDL not been present from zero time (14). 
The data in Fig. 9 indicate that a relatively low rate of LDL degradation in the 
normal cells, and an even lower rate in the FH homozygote cells, is able to keep 
cholesterol synthesis suppressed. Thus, the behavior of  the isolated lymphocytes 
resembles that of confluent, nondividing fibroblasts in which the requirement 
for cholesterol is low enough to be satisfied by a small number of LDL receptors 
(4,  8).  As  shown  in  Fig.  10,  the  addition  of increasing amounts  of LPDS HO,  FAUST,  BILHEIMER,  BROWN,  AND  GOLDSTEIN  1541 
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FIG.  7.  Suppression of  the induction of  cholesterol  synthesis from [~4C]acetate  in normal 
lyrnphocytes by inclusion  of  LDL in the  prior  incubation medium and lack of  such preven- 
tion  by  inclusion  of  HDL. Lymphocytes from  a healthy 25-yr-old  male (S.  A.)  were  incubated 
in  medium A containing 10% lipoprotein-deficient  serum plus the  indicated  fnal concentra- 
tion  of  one of  the following lipoproteins:  I, none; A, HDL; or $, LDL. After incubation at 
37°C  for  48  h,  the  incorporation  of  ['4C]acetate  into  ['4C]cholesterol  was measured by  Method 
I with a 5-h labeling  period.  Each value represents either  the average of  triplicate  incuba- 
tions (m) or single (A, 0) incubations. 
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FIG.  8.  Effect  of LDL  added  at  zero  time  (experiment  A)  or  after  a  56-h  incubation 
(experiment B) on cholesterol synthesis from ['4C]acetate in normal (0, 4) and FH homozy- 
gote (©,  A) lymphocytes. In experiment A, lymphocytes from a healthy 24-yr-old male (S. 
M.) and a 21-yr-old male with homozygous FH (B. H.) were incubated for 68 h in medium A 
containing 10% lipoprotein-deficient serum and the indicated final concentration of LDL, 
after which the incorporation of [14C]acetate into [14C]cholesterol was measured by Method 2 
with a 4-h labeling period. In experiment B, lymphocytes from a healthy 35-yr-old male (D. 
B.) and the same 21-yr-old male with homozygous FH  (B.  H.) were incubated for 56 h  in 
medium A containing 10% lipoprotein-deficient serum, after which each flask received the 
indicated final concentration of LDL. The incubations were continued for an additional 10 h, 
at  which  time  the  incorporation of  []4C]acetate  into  ['4C]cholesterol  was  measured  by 
Method 2 with a  4-h labeling period.  The 100% of control values for the normal and FH 
homozygote  cells  in  experiment A  were  266  and  304  pmol  of  ['4C]acetate  converted  to 
[~4C]cholesterol/h per mg protein, respectively. The 100% of cor/trol values for the normal 
and FH  homozygote  cells in  experiment  B  were  356  and 603,  respectively.  Each  value 
represents the average of duplicate incubations. 1542  CHOLESTEROL  SYNTHESIS  IN  HUMAN  LYMPHOCYTES 
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FIG.  9.  Time-course of degradation of 125I-LDL in normal  (A) and FH homozygote  (A) 
lymphocytes. Lymphocyte from a healthy 24-yr-old male (S. M.) and a 21-yr-old male with 
homozygous FH (B. H.) were incubated in 2 ml of medium A  containing 10% lipoprotein- 
deficient serum and 25/~g protein/ml of 12~I-LDL (44 cpm/ng). After incubation at 37°C for 
the  indicated time,  the content of ~25I-labeled  acid-soluble material  in the medium  was 
determined as described in Materials and Methods. Each value represents the average of 
duplicate incubations. 
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suppress  the induction of cholesterol synthesis from  [14C]acetate in normal  (A) and FH 
homozygote (B) lymphocytes. Lymphocytes from a healthy 22-yr-old male (J. C.) and a 21- 
yr-old  male  with homozygous FH  (B.  H.)  were  incubated in medium A  containing the 
indicated  final  concentration of LDL  and the  indicated  final  concentration  (vol/vol) of 
lipoprotein-deficient serum that had been dialyzed against medium A. After incubation for 
65 h, the incorporation of [~4C]acetate into [14C]cholesterol was measured by Method 2 with 
a  4-h labeling period. Each value represents the average of duplicate incubations. HO,  FAUST,  BILHEIMER,  BROWN,  AND  GOLDSTBIN  1543 
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FIG.  11.  Effect of HDL on the  ability of LDL to  suppress  the induction  of cholesterol 
synthesis from  [14C]acetate  in normal  (A) and FH homozygote (B) lymphocytes. Lympho- 
cytos from a healthy 22-yr-old male (J. C.) and a 21-yr-old male with homozygous FH (B. H.) 
were incubated  in medium A  containing 30%  lipoprotein-deficient serum that  had  been 
dialyzed against medium A and the indicated concentration of LDL in the presence (C)) or 
absence (@) of 1 mg protein/ml of HDL. After incubation at 37°C for 64 h, the incorporation 
of [l~C]acetate into [14C]cholesterol was measured by Method 2 with a 4-h labeling period. 
Each value represents the average of duplicate incubations. 
stimulated the rate of cholesterol synthesis in the FH homozygote cells but not 
significantly in the normal cells incubated in the presence of LDL. 
Another factor that  limited the  ability of LDL to suppress the induction  of 
sterol synthesis was HDL. The data in Fig. llB show that when FH homozygote 
lymphocytes were incubated for 64 h  in the presence of 30% LPDS plus 1 mg 
protein/ml of HDL, the presence of LDL at levels up to 100 ~g protein]ml did not 
significantly suppress the induction of sterol synthesis.  On the other hand,  in 
normal cells the same high level of HDL blunted but did not abolish the LDL- 
mediated suppression of cholesterol synthesis (Fig. llA). HDL did not appear to 
be acting by inhibiting  the degradation  of LDL. As shown in Fig.  12,  freshly 
isolated normal lymphocytes were incubated with varying concentrations of I~I- 
LDL in the presence or absence of 1 mg protein/ml  of HDL and the amount of 
I~I-LDL degraded was measured after 6 and 24 h. The results indicate that HDL 
did not affect the degradation of I~I-LDL either at nonsaturating or saturating 
levels of ~I-LDL. In other experiments, HDL did not inhibit the degradation of 
I~I-LDL over a  time period as long as 72 h. 
A  third  factor that  limited  the  ability of LDL to suppress the induction  of 
sterol synthesis in the FH homozygote, but not in the normal cells was lecithin. 
When the FH cells were incubated for 3 days in the presence of 10% LPDS and 
100 ~g/ml of lecithin, the rate of cholesterol synthesis from ['4C]acetate was 638 
pmol.h -1.mg  -~  in  cells  not  receiving  LDL  and  477  in  cells  to  which  50  ~g 
protein/ml  of LDL had been added at zero time  (75%  of control).  In the same 
experiment,  the rate of sterol synthesis in normal cells incubated in the same 
medium was 1014 pmol. h -~. mg  -1 in cells not receiving LDL and 109 in cells to 
which 50 ~g protein/ml of LDL had been added at zero time (10% of control). 1544  CHOLESTEROL  SYNTHESIS  IN  HUMAN  LYMPHOCYTES 
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FIG.  12.  Failure of HDL to affect the saturation curve for 125I-LDL degradation in normal 
lymphocytes. Lymphocytes from a healthy 24-yr-old male (S. M.) were incubated in medium 
A containing 30% lipoprotein-deficient serum that had been dialyzed against medium A and 
the indicated concentration of I~I-LDL (57 cpm/ng) in the presence (I, &) or absence (©, A) 
of 1 mg protein/ml of HDL. After incubation at 37°C for either 6 h  (©, O) or 24 h  (A, A), the 
content of l~I-labeled acid-soluble material in the medium was determined as described in 
Methods. Each value represents a  single incubation. 
Discussion 
In the current experiments, we have sought to determine whether plasma 
LDL and its cell surface receptor play a  role in the regulation of cholesterol 
synthesis in freshly isolated human lymphocytes. The results indicate that: (a) 
the rate of sterol synthesis is low immediately after normal lymphocytes are 
isolated from the bloodstream; (b) this rate increases 5-15-fold when the cells 
are incubated for 48-72  h  in  LPDS;  (c) after cholesterol synthesis becomes 
elevated it can be suppressed by the subsequent addition of LDL, but not HDL, 
to the incubation medium; and (d) LDL, but not HDL, when added to the cells 
immediately after their isolation from the bloodstream, can prevent the subse- 
quent induction of enhanced sterol synthesis. 
Through the  use  of lymphocytes from FH  homozygotes that  are  severely 
deficient in LDL receptors (14), we have been able to show that aider cholesterol 
synthesis is elevated by incubation of lymphocytes in the absence of lipopro- 
teins, its subsequent suppression by LDL requires the LDL receptor; hence, such 
suppression does not occur in lymphocytes from FH homozygotes. In this re- 
spect, freshly isolated lymphocytes behave similarly to cultured human fibro- 
blasts and lymphoid cells (2, 7, 8, 10). Moreover, in a further analogy with the 
behavior of cultured human cells (10, 20), normal lymphocytes  were also shown 
to respond to LDL with an enhancement in the rate of [14C]oleate incorporation 
into cholesteryl esters, and this response was also lacking in the FH homozygote 
cells. 
On the other hand, it was not possible to demonstrate conclusively that the 
second action of LDL,  namely the suppression of the induction of enhanced 
cholesterol synthesis when the lipoprotein was added to lymphocytes at zero HO,  FAUST,  BILHEIMER,  BROWN,  AND  GOLDSTEIN  1545 
time, was totally dependent on the LDL receptor. This was because LDL had a 
significant ability to suppress the induction of cholesterol synthesis in lympho- 
cytes from FH homozygotes even though these cells were markedly deficient in 
their ability to bind, take up, and degrade the lipoprotein. Two possible explana- 
tions could account for this phenomenon: (a) that this action, although specific 
for LDL and not HDL, is mediated by a mechanism that does not involve the 
LDL receptor, or (5) that this effect requires a small number of LDL receptors 
that is below the limit of reliable detection by direct measurement of I~I-LDL 
binding in the FH homozygote cells. 
Two lines of indirect evidence suggest that the latter explanation may be the 
correct one. First, the suppression of induction of cholesterol synthesis was not 
only specific for LDL but it also occurred at concentratio.ns of the lipoprotein 
similar to those at which binding to the LDL receptor takes place (14). Thus, 
although LDL had only a partial effect on the FH homozygote cells, this effect 
reached a maximum at an LDL concentration of about 50 ~g protein/ml (Figs. 8, 
10, 11), the concentration at which the LDL receptor in normal lymphocytes is 
saturated  (14). Second, a  trace amount of high affinity l~I-LDL degradation 
(<5%  of that  observed in  normal subjects) has  been detected previously in 
lymphocytes from receptor-negative FH homozygotes incubated for 72 h in the 
absence of lipoproteins (14). These data suggest the presence of a small number 
of LDL receptors in lymphocytes from some patients whose fibroblasts appear 
completely devoid of receptor activity as determined within the sensitivity of 
present assays. 
If nondividing cells  such  as  lymphocytes require  only  small  amounts  of 
cholesterol for structural purposes, it is possible that a small amount of LDL 
receptor activity and a consequent low rate of LDL degradation in FH homozy- 
gote lymphocytes  might be capable of supplying sufficient cholesterol to balance 
cellular losses so long as LDL is maintained continuously for several days in the 
incubation medium. On the other hand, if lymphocytes are first incubated for 
several days in the absence of LDL so that they develop an enhanced require- 
ment for cholesterol as evidenced by the development of an enhanced rate of 
cholesterol synthesis,  then  the  small  number of LDL  receptors  in  the  FH 
homozygote cells is insufficient to allow a rapid uptake of cholesterol when LDL 
is added back to the medium. Consequently, endogenous cholesterol synthesis 
remains high in the mutant cells as compared to the suppressed level in the 
normal cells. 
Additional evidence supports the hypothesis that a  small number of LDL 
receptors can satisfy the requirement for cholesterol in lymphocytes only when 
that requirement is minimal. Thus, three agents that are believed t5 enhance 
the removal of cholesterol from cells (namely, LPDS, plasma HDL, and lecithin) 
(8,  30-33) all render FH homozygote cells resistant to the action of LDL in 
suppressing the  induction of cholesterol synthesis.  Thus,  in the presence of 
agents that increase the cellular requirement for cholesterol normal cells are 
able to degrade LDL at a  rate sufficient to keep sterol synthesis suppressed. 
However, the low rate of LDL degradation in FH homozygote cells is unable to 
supply the cells with sufficient cholesterol under these conditions and hence 
sterol synthesis is enhanced. 1546  CHOLESTEROL  SYNTHESIS  IN  HUMAN  LYMPHOCYTES 
An important finding in the current studies was the observation that the rate 
of cholesterol synthesis in freshly isolated lymphocytes from 4 different FH 
homozygotes was the same as that in  17  normal subjects.  This normal rate 
presumably reflects the fact that before their removal from the body these 
mutant lymphocytes  were exposed to plasma LDL-cholesterol levels that were at 
least 6-fold above normal and approximately 100-fold greater than the level 
required to maintain a suppression of cholesterol synthesis in nondividing cells 
in vitro. In contrast to these findings in the FH homozygotes, lymphocytes  from 
two patients  with  abetalipoproteinemia, which have  never been exposed to 
plasma LDL,  showed rates of cholesterol synthesis that were two to fourfold 
above those in cells of normal subjects immediately  after their isolation from the 
bloodstream. This enhanced rate of cholesterol synthesis did reflect a degree of 
partial suppression, however, since the rate of cholesterol synthesis in lympho- 
cytes from these abetalipoproteinemia subjects increased an additional three to 
sixfold when these cells were incubated for 72 h in the absence of lipoproteins 
(data not shown). The factors responsible for the partial suppression of choles- 
terol synthesis in abetalipoproteinemia lymphocytes in vivo are not known. 
Despite the differences in the plasma level of LDL, in the number of LDL 
receptors, and in the rate of cholesterol synthesis in lymphocytes from normal 
subjects, FH homozygotes, and patients with abetalipoproteinemia, the cellular 
content of free and esterified cholesterol was indistinguishable among the three 
groups. These data emphasize the ability of the various control mechanisms to 
adapt to  metabolic derangements arising from different mutations affecting 
LDL metabolism so as to keep the intracellular cholesterol content constant. In 
abetalipoproteinemia, in which plasma LDL is absent, compensation is achieved 
at least in part through an enhanced rate of cellular sterol synthesis; whereas in 
homozygous FH, in which LDL receptors are markedly deficient, compensation 
is  achieved at  least  in  part  through an  elevation in  plasma  LDL.  Similar 
findings of elevated cholesterol synthesis in fresh skin slices from two abetalipo- 
proteinemia subjects and a normal cholesterol synthesis rate in skin slices from 
one FH homozygote have previously been reported (34). 
The finding of an  induction of enhanced cholesterol synthesis in  normal 
lymphocytes  incubated in vitro in the absence of lipoproteins correlates with the 
previously reported increase in sterol synthesis that occurs after similar incuba- 
tion of mixed leukocytes (35-37). On the other hand, the results in the current 
studies differ from those expected on the basis of previous reports that mixed 
leukocytes  from FH heterozygotes showed a more rapid enhancement  in the rate 
of sterol synthesis than did normal leukocytes incubated in delipidized serum 
(36). In the current studies, lymphocytes from FH homozygotes did not show a 
more rapid enhancement  in the rate of cholesterol synthesis than did the normal 
cells when incubated in LPDS. Moreover, when lymphocytes  were incubated for 
72 h in the absence of lipoproteins, no consistent difference  was noted in the rate 
of cholesterol synthesis between the normal and FH homozygote cells, indicat- 
ing that under the conditions of these experiments the FH homozygote cells did 
not exhibit an enhanced effiux of cholesterol from the cell as has been proposed 
to occur in mixed leukocytes isolated from FH heterozygotes (36). Whether the 
differences in these results reflect the difference in genotype of the FH patients HO,  FAUST,  BILHEIMER,  BROWN,  AND  GOLDSTEIN  1547 
(heterozygotes  vs. homozygotes), a difference  in the type of  cell preparation used 
(mixed leukocytes vs. lymphocytes), or a  difference in methodology employed 
(incubation in delipidized serum vs. LPDS) remain to be determined. 
Summary 
The rate of  cholesterol synthesis from [14C]acetate was low in circulating blood 
lymphocytes freshly isolated from 17 normal subjects and 4 subjects with homo- 
zygous FH.  On the other hand,  the rate of cholesterol synthesis was two to 
fourfold above normal in freshly isolated lymphocytes from two subjects with 
abetalipoproteinemia. When the lymphocytes  from subjects with all three geno- 
types were incubated for 48-72  h  in the absence of lipoproteins,  the rate of 
cholesterol synthesis increased by 5-15-fold. The subsequent addition of plasma 
LDL, but not HDL, rapidly suppressed cholesterol synthesis in the lymphocytes 
from normal  subjects.  In  contrast,  lymphocytes from the  FH  homozygotes, 
which have been shown previously to be deficient in cell surface LDL receptors, 
were resistant to LDL-mediated suppression of cholesterol synthesis. 
In addition to its ability to suppress cholesterol synthesis after it had been 
elevated by incubation of the cells in the absence of lipoproteins, LDL was able 
to suppress the induction of the enhanced rate of sterol synthesis when added to 
normal lymphocytes immediately after their isolation from the bloodstream. In 
contrast to the former action of LDL, the latter action of LDL-i.e., the suppres- 
sion of induction of sterol synthesis-also occurred to a limited extent in lympho- 
cytes from FH homozygotes. However, the FH lymphocytes, but not the normal 
cells, could be made resistant to this action of LDL by inclusion in the incuba- 
tion  medium of lipoprotein-deficient serum  (30%, vol/vol)  plus  HDL  (1  mg 
protein/ml). Considered together with previous data demonstrating a deficiency 
of LDL receptors in freshly isolated lymphocytes from FH homozygotes, the 
current studies provide evidence in support of the hypothesis that the interac- 
tion of plasma LDL with its cell surface receptor serves to regulate cholesterol 
synthesis in human lymphocytes. 
Received for publication 3 January 1977. 
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